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1. Introduction
Rectourethral fistulas (RUFs) are tracts that pathologically
connect the rectum to the urethra. They usually represent a
rare but significant complication of radical prostatectomy
and one that is difficult to resolve [1]. RUFs are usually
located at or near the vesico-urethral anastomosis and the
membranous urethra [2]. RUF incidence varies from 0.6% to
9% [3,4]. Intraoperative accidental rectal injury is a major
risk factor for the formation of a fistula [5].
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Abstract
Background: Rectourethral fistulas (RUFs) represent an uncommon complication of
pelvic surgery, especially radical prostatectomy. To date there is no standardised
treatment for managing RUFs. This represents a challenge for surgeons, mainly because
of the potential recurrence risk.
Objective: To describe our minimally invasive transanal repair (MITAR) of [6_TD$DIFF]RUFs and to
assess its safety and outcomes.
Design, setting, and participants: We retrospectively evaluated 12 patients who under-
went MITAR of RUF at our centre from October 2008 to December 2014. Exclusion
criteria were a fistula diameter greater than 1.5 cm, sepsis, and/or faecaluria.
Surgical procedure: After fistula identification through cystoscopy and 5F-catheter
positioning within the fistula, MITAR is performed using laparoscopic instruments
introduced through Parks’ anal retractor. The fibrotic margins of the fistula are carefully
dissected by a lozenge incision of the rectal wall, parallel to the rectal axis. Under the
healthy flap of the rectal wall the urothelium is located and the fistulous tract is sutured
with interrupted stitches. After a leakage test of the bladder, the rectal wall is sutured
with interrupted stitches. Electrocoagulation is never used during this procedure.
Measurements: Fistula closure, postoperative complications, and recurrence.
Results and limitations: Median follow-up was 21 (range, 12–74) mo. Median operative
time was 58 (range, 50–70) min. Median hospital stay was 1.5 (range, 1–4) d. Early
surgical complications occurred in one patient (8.3%). Recurrence did not occur in any of
the cases. Limitations included retrospective analysis, small case load, and lack of
experience with radiation-induced fustulas.
Conclusions: MITAR is a safe, effective, and reproducible procedure. Its advantages are
low morbidity and quick recovery, and no need for a colostomy.
Patient summary: We studied the treatment of rectourethral fistulas. Our technique,
transanally performed using laparoscopic instruments, was found to be safe, feasible,
and effective, with limited risk of complications.
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With the improvements in multimodal prostate cancer
(PCa) treatments, the incidence of fistulas induced by
brachytherapy, cryotherapy, or radiotherapy (RT) has risen
[6]. These fistulas are usually large (> 1.5 cm) and difficult
to treat because they present thick, fibrotic hypovascular
surrounding tissue [7].
Several techniques can be used for managing RUFs:
transanal, transabdominal, trans-sphincteric, and transper-
ineal; the last being most commonly adopted [6]. To date no
standardised RUF treatment exists. In fact, the majority of
published studies concern single institution experiences,
small case series, or single case reports. RUF treatment
represents a challenge for surgeons, especially because of
the risk of potential recurrence.
The aim of this paper is to report our experience with a
minimally invasive transanal repair (MITAR) technique
performed for treating fistulas smaller than 1.5 cm using
laparoscopic instruments, and no need for colostomy. Our
procedure precludes the interposition of a tissue flap
between the rectum and the urothelium after their repair.
For this reason our technique is not appropriate for
treating fistulas at a high risk of recurrence in which case
it is advisable to separate the sutures by a buffer tissue
[8].
2. Patients and methods
2.1. Study population and design
From October 2008 to December 2014, 12 patients (1.2%) out of a total of
983 RPs (324 open and 659 robotic) developed RUF suitable for MITAR.
Exclusion criteria for minimally invasive repair were fistula diameter
greater than 1.5 cm, sepsis, and/or faecaluria. We arbitrarily set the cut-
off value at 1.5 cm because this already represents a wide fistula and it
becomes wider after fibrotic margin resection.
Baseline patient characteristics are listed in Table 1. Open radical
retropubic prostatectomy was performed in four patients, while robotic-
assisted radical retropubic prostatectomy was performed in eight. In
four patients, out of eight intraoperatively detected rectal injuries, the
fistula resulted from a failure of a two-layer suture.
Median age at MITAR was 63 yr (range, 54–71). Clinical suspicion
was aroused by pneumaturia, cloudy urine, and urinary rectal discharge.
These appeared after a median of 13 d (range, 2–26). No patient
presented copious faecaluria at diagnosis. None had either diabetes
mellitus or inflammatory bowel disease. One patient had undergone
bowel surgery for sigmoid diverticula 7 yr prior.
Preoperative diagnosis was obtained by digital rectal examination,
cysto-urethroscopy [7_TD$DIFF], cystourethrogram, and computed tomography scan.
We reserve sigmoidoscopy, as a part of the evaluation, for recurrent or
radiation-induced RUFs to evaluate the eventual inflammatory proctitis,
to exclude a colonic cancer, and to define the extent of radiation injury.
After RUF diagnosis all patients underwent bladder catheterisation
along with oral antibiotic therapy and a low residue diet for at least 4 wk.
Spontaneous fistula closure did not occur in any of the cases.
2.2. Surgical technique
2.2.1. Preoperative preparation and instrumentation
On the day before surgery, patients were given a clear liquid diet. Bowel
clearance was obtained by polyethylene glycol laxative administration
the evening before surgery.
In order to perform the procedure we used the Parks’ anal retractor,
laparoscopic instruments (a 308 camera, curved scissors, a needle holder [8_TD$DIFF],
a knot pusher [2_TD$DIFF] and an aspirator), and a number 15 surgical scalpel blade.
To reduce the risk of tissue necrosis we did not use electrocoagulation.
2.2.2. Patient positioning
As shown in the Supplementary Video, the operation consisted of an
initial cystoscopy followed by the transanal procedure. Initially the
patient was placed in the lithotomy position. During cystoscopy a 5F
catheter was placed within the fistula; it was retracted through the anus,
and an 18F bladder catheter was introduced. The patient was then placed
in a prone jack-knife position.
2.2.3. Incision of the rectal wall
After introducing the Parks’ anal retractor, the fibrotic margins of the
fistula were carefully dissected through a lozenge incision of the rectal
wall, performed parallel to the major rectal axis with a number
15 surgical scalpel blade (Fig. 1). Laparoscopic scissors were used to
carve the edges of the rectal wall until soft, healthy tissue was reached
(Fig. 2). All excised tissue was sent to the pathologist to be analysed.
2.2.4. Urothelial wall suturing
Under the healthy flap of the rectal wall the urothelial wall was located
and the fistulous tract was sutured, without any additional tissue
removal, using interrupted Vicryl 3.0 stitches. In order to close the
fistulous tract we passed the first two stitches over and under the 5F
catheter. The catheter was then removed and we made an additional
Table 1 – Baseline patient characteristics
Case no. Age BMI pT PCa Gleason score Procedure RUF symptoms appearance (d)
1 63 28.5 pT2c 3 + 3 RRP 2
2 54 27 pT2a 3 + 4 RRP 14
3 69 29 pT3a 3 + 3 RRP 19
4 71 25.5 pT2b 4 + 3 RARP 16
5 48 28 pT3a 4 + 3 RARP 24
6 57 32 pT2c 4 + 5 RARP 9
7 69 26.5 pT3a 4 + 4 RARP 11
8 63 30.5 pT3a 3 + 4 RRP 26
9 58 29 pT3b 4 + 5 RARP 5
10 70 24 pT2b 3 + 3 RARP 7
11 62 26 pT3b 4 + 3 RARP 20
12 64 29.5 pT3a 3 + 4 RARP 11
BMI = body mass index; PCa = prostate cancer; RARP = robot-assisted radical prostatectomy; RRP = radical retropubic prostatectomy; RUF = rectourethral [3_TD$DIFF]fistula.
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stitch to make the suture watertight. A leakage test of the bladder with
300-ml saline solution was performed.
2.2.5. Rectal wall suturing
We then trimmed the incised rectal edges until we obtained a healthy
wide soft flap, which, when sewn, slid easily to cover the underlying
urothelial sutures. We made deep-bite stitches using 3.0 Vicryl thread
and we knotted them. After rectal wall suturing, a second leakage test
was performed.
2.3. Postoperative course
All patients were admitted to the urological ward. A Visual Analogue Scale
questionnaire was completed by all patients on the 1st postoperative day.
A clear liquid diet was administered after the procedure and
continued during Postoperative Day 1, and then a residue-free diet was
initiated. Over a week patients gradually advanced to a normal diet. All
patients were treated with intravenous ceftriaxone twice a day on the
day of surgery, and intramuscular ceftriaxone was administered for 4 d.
All patients were discharged with urinary catheter in situ.
2.4. Postoperative follow-up
The bladder catheter was removed 20 d from surgery following a
cystourethrogram examination. Follow-up visits were scheduled at 3 mo
and 12 mo postsurgery. A phone interview concerning recurrence and
complications was conducted with all patients before data analysis.
We defined successful fistula closure as resolution of clinical symptoms
along with radiographic confirmation through cystourethrogram.
3. Results
Detailed postoperative results are listed in Table 2. Median
follow-up: 21 mo (range, 12–74). Median operative time
was 58 min (range, 50–70). On Postoperative Day 1 patients
referred no more than 4 (median: 3, range, 2–4) on a Visual
Analogue Scale (0 = no pain, 10 = unbearable pain). Median
hospital stay was 1.5 d (range, 1–4). Estimated blood loss
[(Fig._1)TD$FIG]
Fig. 1 – Lozenge incision of the rectal wall.
[(Fig._2)TD$FIG]
Fig. 2 – Carving the rectal wall’s edges in order to reach healthy tissue.
Table 2 – Postoperative results
Case no. Operative time (min) VAS on Day 1 Hospital stay (d) Follow-up (mo) Time between prostatectomy and MITAR (d)
1 60 3 1 74 60
2 55 3 1 61 69
3 50 2 2 43 72
4 60 2 1 31 71
5 50 3 1 25 76
6 60 2 4 22 58
7 70 4 2 20 60
8 50 3 1 18 78
9 50 2 2 15 61
10 60 3 3 13 57
11 60 3 1 13 73
12 50 2 2 12 62
MITAR = minimally invasive transanal repair; VAS = Visual Analogue Scale.
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was lower than 50 ml in all cases. Postoperative course was
uneventful in all but one patient (8.3%), who developed
cystitis after the procedure and was treated with intrave-
nous antibiotics. The 30-d Clavien complication rate was
8.3% due to a Grade II complication. No later complications
have been observed.
MITAR had been curative in all patients, and no cases of
urinary or faecal incontinence occurred secondary to the
procedure, or any cases of urethral stenosis. Cancer was not
found in any of the specimens. Median time between
prostatectomy and MITAR was 66 d (range, 57–78).
4. Discussion
Various surgical strategies for RP can be adopted: retro-
pubic, perineal, laparoscopic, and robotic [9]. Each of these
techniques has the risk of accidental rectal wall injury,
which is considered a major risk factor for RUF formation
[5,7]. During RP the rate of accidental lesions to the anterior
rectal wall ranges from 0.12% to 11% [5,10]. Intraoperative
recognition of these lesions and their treatment reduces the
risk of RUFs up to 87% [5]. Thus, a careful evaluation of
anterior rectal wall integrity is advisable during every
prostatectomy after the removal of the specimen
[5,7,11]. At our institution, after RP we always check for
possible iatrogenic rectal damage using the method
described by Pisters and Wajsman [12]. If a rectal injury
is located, it is repaired by two-layer closure with no tissue
interposition.
Among the various approaches to RP, the perineal one is
associated with a higher incidence of RUF [7]. At our
institution we adopt the retrograde retropubic approach for
open RP and the anterograde approach for robotic-assisted
RP. Given that the majority of RPs are performed with
robotic assistance, eight out of a total of 12 RUFs were
secondary to robotic-assisted RP.
In recent years, the great diffusion of radiotherapy and
brachytherapy in the treatment of PCa has determined a
significant increase of radiation-induced RUFs [13,14]. In-
deed, while previous studies reported a radiation-induced
fistula rate of 4%, more recently almost 40–50% of RUFs can
be attributable to radiotherapy [6,15]. If radiotherapy is
administered as neo-adjuvant, during salvage prostatec-
tomy up to 15% risk of rectal injury is reported because of
induced fibrosis in the surrounding tissues [16]. Usually
nonradiated RUFs are smaller than radiated or ablative
RUFs. Furthermore, fistulas that develop in patients after
multimodal PCa treatment are often fibrotic and have
hypovascular surrounding tissue [7]. Vanni et al. [15]
demonstrated that radiation-induced RUFs can be repaired
with muscle flap and buccal mucosal interposition with
neither urinary nor faecal diversion, achieving an 84%
success rate. By contrast, Linder et al. [17] reported that 93%
of patients with radiation- or ablation-induced fistulas
required permanent urinary diversion and 86% permanent
colostomy. Further data are necessary to assess the best
treatment for radiation- or ablation-induced fistula.
RUFs can also appear after RP even if no documented
rectal wall damage is found intraoperatively [3,5] and in
absence of adjuvant or neo-adjuvant multimodal treat-
ments. These fistulas are usually smaller than radiation-
induced RUFs and usually represent the best candidate for
MITAR. Eight patients (66.7%) in our series developed RUF
with no intraoperative documented iatrogenic rectal wall
damage.
RUF diagnosis is relatively simple. Its symptomatic
spectrum consists of rectal passage of urine, pneumaturia,
urinary tract infections, and faecaluria [3,6]. Faecaluria is a
negative prognostic factor because usually it is associated
with a large diameter fistula [7]. Faecal diversion is not
necessarily routine but should be mandatory in cases of
copious faecaluria. As a general rule, when the repair is not
tight faecal diversion is advisable as part of the reconstruc-
tion [8].
Along with retrograde urethrography and cystoscopy,
computed tomography or magnetic resonance imaging
allows anatomical and dimensional identification of the
fistula. The evaluation of fistula determining factors and
symptoms, accompanied by imaging studies, constitutes a
crucial step in planning the subsequent approach.
In the absence of faecaluria, for small and nonradiation-
induced fistulas a conservative approach may be attempted.
This relies on urethral [9_TD$DIFF]catheterization alone or on urethral
[9_TD$DIFF]catheterization and faecal diversion. Noldus et al. [18]
reported that seven of 13 patients (54%) had spontaneous
fistula closure after urethral [9_TD$DIFF]catheterization for no longer than
3 mo. Thomas et al. [7] reported spontaneous fistula closure in
three patients managed with urethral [9_TD$DIFF]catheterization alone
after 28 d, 29 d, and 100 d, while when performing both
urethral [9_TD$DIFF]catheterization and faecal diversion for fistulas
associated with faecaluria or systemic symptoms, literature
reports variable percentages of therapeutic success of the
conservative treatment, precisely 14% [19], 33% [7], and 46%
[20]. Given the lack of uniformity of data, further results are
needed to assess the role of conservative approaches in RUF
treatment. Indeed, a conservative approach with indwelling
bladder catheter should always be attempted. After RUF
diagnosis was made, all our patients underwent bladder
catheterisation along with oral antibiotic therapy and a
residue-free diet. After 4 wk, spontaneous fistula healing did
not occur in any of the cases.
Concerning surgical options, a review of RUF treatment
demonstrated that faecal diversion through ileostomy or,
more commonly, colostomy is often performed, and that the
perineal approach is the most commonly adopted in
preference to the transanal, transabdominal, and transrectal
techniques [6]. The Kraske laterosacral technique is not
recommended for RUF because of poor urethral exposure
[21]. Regardless of the surgical technique adopted, fistula
closure can be effective in up to 87.5% of cases, with a
recurrence rate of 12.5% [6]. Since there is no standardised
treatment, the choice of the surgical technique is usually
determined by the surgeon’s familiarity with a given
procedure. The transabdominal approach is the most
commonly adopted in cases of radiation or ablation-
induced RUF [14,22–24].
The transanal approach is the least commonly used. The
Latzko method can accomplish results similar to the other
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techniques [6]. It has the advantage of not involving the
division of the anal sphincter. Nevertheless, it is classically
criticised because of the limited manoeuvrability of the
instruments in the narrow surgical field [6,25]. The use of
laparoscopic instruments allows the surgeon to overcome
this problem. Furthermore, our technique has shown itself to
be effective in all patients and can be adopted for treating
small fistulas, determining low morbidity and quick recovery.
In literature there is also evidence of minimally invasive
transanal approaches for RUF [26–29]. Wilbert et al. [26]
reported two cases of RUF managed with transanal
endoscopic microsurgery (TEM) along with transurethral
fibrin application; in one case colostomy was required
because of faecaluria. Quinlan et al. [27] and Bochove-
Overgaauw et al. [28] exclusively adopted a TEM approach
for RUF. Quinlan et al. [27] did not perform faecal diversion,
while Bochove-Overgaauw et al. [28] performed a colosto-
my in both their patients. Atallah et al. [29] used transanal
minimally invasive surgery for treating a case of RUF after
performing an ileostomy. A rectoscope was used by Wibert
et al. [26], Quinlan et al. [27], and Bochove-Overgaauw et al.
[28], while Atallah et al. [29] performed the procedure
through a SILS port. The fistula was excised with
electrocautery by all four study groups [26–29]. In five
cases out of six, the transanal minimally invasive procedure
resulted effective [26–29]; in one case the procedure,
performed after the failure of a gracilo-plasty, failed to
resolve the RUF [29]. In TEM and transanal minimally
invasive surgery the rectum is distended with carbon
dioxide insufflation, whereas we use the Parks’ anal
retractor to perform MITAR, because it provides good
exposure and enough space to work in the surgical field.
Since our 2013 preliminary report of MITAR performed
in four patients [30], we have not changed the procedure.
Ours is currently the largest case load concerning a
minimally invasive transanal approach for treating RUFs.
Some limitations of our study are the small case load,
retrospective analysis, and lack of experience for treating
fistulas larger than 1.5 cm or radiation-induced RUFs. We do
not exclude the possibility that this procedure is feasible in
these circumstances, but faecal diversion may prove
necessary. Further results are needed to assess the
effectiveness of MITAR under these circumstances.
5. Conclusions
MITAR is a safe, feasible, and reproducible procedure
performed with laparoscopic instruments on a patient in
a prone jack-knife position. Laparoscopic instruments allow
us to work in the narrow surgical field and to reduce
surgical trauma.
This minimally invasive approach is curative for small
fistulas. Since colostomy is not needed, both hospital stay
and morbidity are significantly low; moreover, it achieves
quick recovery. Careful patient selection is mandatory.
Clinical symptoms together with RUF dimension should
determine the therapeutic options. Fistulas with a diameter
smaller than 1.5 cm in the absence of sepsis and/or
faecaluria can be treated with MITAR.
Further results are needed to assess the effectiveness of
this technique in treating larger and/or radiation-induced
fistulas.
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